Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method

Endoscopic retrograde endoscopic retrograde cholangiopancreatography (ERCP) is widely used for the diagnosis and treatment of pancreatic and biliary tract disease. However, post-ERCP pancreatitis (PEP) is the most common adverse event following the procedure, ranging from 2% to 10% in nonselective cases, and it can cause substantial morbidity, mortality, or high medical costs. Recent advances in cannulation technique and accessories for biliary cannulation have contributed to reduce the incidence of PEP, but biliary cannulation can fail in 5% to 20% of cases of ERCP. Suprapapillary needle-knife fistulotomy (NKF), with or without large-diameter balloon dilation, has been used as a rescue method in cases of difficult biliary cannulation, and NKF was recommended as an initial approach to selective biliary cannulation in cases of repetitive unintentional pancreatic cannulation.9 Moreover, difficult biliary cannulation is known to be a risk factor for PEP, and it has been reported that NKF is associated with a low risk of PEP. Thus, we hypothesized that NKF may reduce the risk of PEP in patients who are at increased risk for PEP.

Inclusion criteria

• Patient who submitted a written informed consent for the this trial, and 18 ~ 90 years old
• Patient who have naïve ampulla (no previous procedure was performed at ampulla)
• Patient who is suspected to have biliary obstruction or biliary disease
• Patient who is needed to have endoscopic retrograde cholangiopancreatography for treatment of biliary obstruction
• Patient who have risks of post-endoscopic retrograde cholangiopancreatography pancreatitis among bellows (at least one more);

• suspected biliary sphincter of Oddi dysfunction
• young age (18~50 years)
• female
• normal common bile duct diameter (≤9mm)
• normal serum bilirubin level
• Obesity (body mass index > 30)
• Past history of acute pancreatitis

Exclusion criteria

• Patient who is below 18 year old
• Patient who is pregnant
• Patient with mental retardation
• Patient is sensitive to contrast agents
• Patient who received sphincterotomy or pancreatobiliary operation previously
• Patient who have ampulla of Vater cancer
• Patient who have difficulty for approach to ampulla due to abdominal surgery including stomach cancer with Billroth II anastomosis
• Patient who have pancreatic diseases as bellow (at least one more);

• Patient who have acute pancreatitis within 30days before enrollment
• Patient who have idiopathic acute recurrent pancreatitis
• Patient who have pancreatic divisum
• Patient who have obstructive chronic pancreatitis
• Patient who pancreatic cancer
• Patients who have improper ampulla shape as bellows;

• Small ampulla (ampulla without oral protrusion)
• Flat or crooked or asymmetric ampulla
• Ampulla with peri-ampullary diverticulum type I or II